CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes. Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.
In 2017, the global CRISPR/Cas9 market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

This report focuses on the global CRISPR/Cas9 status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CRISPR/Cas9 development in United States, Europe and China.

The key players covered in this study
Caribou Biosciences
Integrated DNA Technologies (IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego

Market segment by Type, the product can be split into
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering

Market segment by Application, split into
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global CRISPR/Cas9 status, future forecast, growth opportunity, key market and key players.
To present the CRISPR/Cas9 development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of CRISPR/Cas9 are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.